Stay updated on IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial

Sign up to get notified when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:42:46.000Z thumbnail image
  6. Check
    12 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a shift in the safety and efficacy evaluation of A4250 in patients with Primary Biliary Cirrhosis and cholestatic pruritus. This change reflects an update in the study's assessment of treatment-emergent adverse events and safety parameters related to liver and kidney function tests.
    Difference
    0.1%
    Check dated 2024-06-06T14:42:21.000Z thumbnail image
  7. Check
    26 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    27%
    Check dated 2024-05-22T21:31:05.000Z thumbnail image
  8. Check
    48 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:40:12.000Z thumbnail image

Stay in the know with updates to IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IBAT Inhibitor A4250 for Cholestatic Pruritus Clinical Trial page.